IGHD II, the most common genetic form, is characterized by short stature and delayed bone age, accompanied by laboratory findings of low but detectable serum GH and reduced insulin-like growth factor 1 (IGF-1) levels. This evidence concerns the gene IGF1 and isolated growth hormone deficiency type II.